Asparkam - a source of magnesium and potassium. The drug normalizes electrolyte balance, regulates metabolic processes in the body, has an antiarrhythmic effect.
Release form and composition
Make tablets and solution for infusions Asparkam.
1 tablet contains:
- Potassium aspartate - 175 mg;
- Magnesium aspartate - 175 mg.
10 ml of Asparkam solution contain:
- Potassium asparaginata - 0.45 g;
- Magnesium asparaginata - 4 g.
Indications for use
According to the instructions, Asparkam prescribed for:
As an auxiliary drug, Aspark is indicated for:
- Coronary heart disease;
- Chronic circulatory failure;
- Shock states.
Asparks are also prescribed for cardiac rhythm disturbances caused by the lack of magnesium or potassium in the body, the toxic effects of digitalis preparations or their intolerance, atrial fibrillation paroxysms, and ventricular extrasystoles.
According to the instructions, Asparkam is contraindicated in:
- Severe myasthenia;
- AV blockade;
- Acute or chronic renal failure.
Dosing and Administration
Asparkam tablets are intended for internal use. The drug is prescribed after a meal. The dosage for adult patients is 1-2 tablets three times a day for 0.5-1 months.
Solution for infusion Asparks injected intravenously drip or jet. The dosage of the drug is determined for each patient separately, depending on the evidence and condition. The drug is administered intravenously at a rate of 25 drops per minute in 10-20 ml 1-2 times a day. To prepare the infusion, 1-2 ampoules of 10 ml each or 2-4 ampoules of 5 ml should be diluted in 100-200 ml of 5% glucose solution or isotonic sodium chloride solution.
When sprayed, the contents of 1 ampoule of Asparkam 10 ml or 2 ampoules 5 ml diluted in 20 ml of 5% glucose solution or sterile water for injection and injected into a vein at a rate of 5 ml per minute.
The use of Asparkam may cause the following side effects:
- The digestive system: nausea, vomiting, diarrhea, bleeding from the organs of the gastrointestinal tract, the expression of the mucous membrane of the gastrointestinal tract, abdominal pain, dry mouth, flatulence;
- Cardiovascular system: bradycardia, lowering blood pressure, paradoxical reaction (increase in the number of extrasystoles), AV blockade;
- Other reactions: vein thrombosis, pruritus, dyspnea, phlebitis, dizziness, sweating, asthenia, paresthesia, hyporeflexia.
With the rapid introduction of Asparkam or its use in high doses, hypermagneemia or hyperkalemia may develop, accompanied by the following symptoms:
- Muscle hypotonus;
- Paresthesia of the limbs;
- Muscular paralysis;
- AV conduction disturbance;
- Heart failure.
In case of overdose, the patient needs to use inside or intravenous solution of sodium chloride, intravenous infusion of 300-500 ml of 5% dextrose solution. If necessary, hemodialysis and peritoneal dialysis should be performed.
The use of Asparkam during pregnancy and breastfeeding is possible only after consulting a doctor.
With the simultaneous use of Asparkam with ACE inhibitors or potassium-sparing diuretics, the risk of hyperkalemia increases. Therefore, patients taking these drugs at the same time are advised to monitor plasma levels of potassium.
If necessary, the introduction of strophanthin and foxglove drugs with Asparkam is allowed.
In myocardial infarction, overdose with cardiac glycosides, ectopic arrhythmias Asparks in the composition of the polarizing mixture (in combination with insulin and dextrose) normalizes the rhythm of cardiac activity.
The following drugs are analogues of Asparkam:
- Potassium and magnesium asparaginate;
Terms and conditions of storage
According to the instructions, Asparkam should be stored in a dry dark place out of the reach of children. Shelf life of the drug is 2 years.